Industry
Drug Manufacturers - Specialty & Generic
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
Loading...
Open
0.48
Mkt cap
1.7M
Volume
112K
High
0.50
P/E Ratio
-0.14
52-wk high
6.39
Low
0.45
Div yield
N/A
52-wk low
0.43
Portfolio Pulse from Benzinga Newsdesk
October 08, 2024 | 4:21 pm
Portfolio Pulse from Benzinga Newsdesk
October 07, 2024 | 8:18 pm
Portfolio Pulse from Benzinga Newsdesk
October 02, 2024 | 11:59 am
Portfolio Pulse from Avi Kapoor
September 11, 2024 | 9:16 am
Portfolio Pulse from Benzinga Insights
May 20, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Insights
May 17, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Insights
May 07, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Insights
April 18, 2024 | 8:31 pm
Portfolio Pulse from Avi Kapoor
April 17, 2024 | 5:36 pm
Portfolio Pulse from Benzinga Insights
April 17, 2024 | 4:31 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.